The US Food and Drug Administration, which had initially rejected the application, has given the company the green light, several years after the tech billionaire first promised testing would begin
brain chip firm Neuralink has said it has been given the go-ahead to start carrying out studies on humans.
Neuralink said in a tweet on Thursday it had won the approval of the US Food and Drug Administration (FDA) “to launch our first-in-human clinical study!”
It represents “an important first step that will one day allow our technology to help many people,” it said.
The billionaire has said Neuralink would begin human trials at least four times since 2019, but the company only applied for FDA approval early last year.
The agency turned it down then – major issues involved the implant’s lithium battery, the possibility of its wires migrating within the brain, and whether the device could be safely removed without damaging brain tissue – and said the concerns needed to be addressed before sanctioning human trials.
Product of the Day
Has Technology gone to far? Please leave a comment below.